mhra suspends recruitment to covid-19 hydroxychloroquine trials
mhra suspends recruitment to covid-19 hydroxychloroquine trials
we followed the emerging concerns about use of hydroxychloroquine in covid-19, and took into consideration the results from two different trials, including the uks recovery trial which has provided convincing evidence of no meaningful mortality benefit in hospitalised patients with covid-19.", "the mhra took into consideration the results released from the recovery trial, showing no beneficial effect of hydroxychloroquine in patients hospitalised with covid-19, and a new england journal of medicine publication using hydroxychloroquine as postexposure prophylaxis of covid-19, concluding that hydroxychloroquine did not prevent illness compatible with covid-19 or confirmed infection."


































)